Company Filing History:
Years Active: 2009-2019
Title: Innovations of Jean-Robert Brisson
Introduction
Jean-Robert Brisson is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of immunology through his innovative research and patents. With a total of 2 patents, Brisson's work focuses on novel compounds that have potential applications in vaccine development.
Latest Patents
Brisson's latest patents include groundbreaking discoveries in lipoteichoic acid and Campylobacter glycans and glycopeptides. The first patent details a novel lipoteichoic acid (LTA) isolated from specific sources, with a structure that allows for various fatty acid combinations. This invention encompasses methods for conferring immunity through vaccines produced using the isolated LTA and its conjugates. The second patent addresses the common glycan moiety found in multiple strains of Campylobacter, which has implications for vaccine development against infections in both humans and animals. This glycan can be linked to amino acids to form glycopeptides, and methods for determining its structure have been established.
Career Highlights
Brisson is affiliated with the National Research Council of Canada, where he conducts his research. His work has been instrumental in advancing the understanding of immunological responses and developing new vaccine strategies.
Collaborations
Brisson has collaborated with notable colleagues, including Noel M. Young and John Francis Kelly, to further enhance the impact of his research.
Conclusion
Jean-Robert Brisson's contributions to immunology through his patents and research at the National Research Council of Canada highlight his role as an influential inventor in the field. His innovative work continues to pave the way for advancements in vaccine development and disease prevention.